HittRYoung-XuYSilverM, et al.Centenarians: The older you get, the healthier you have been. Lancet1999; 354: 652–652.
2.
Lloyd-JonesDMBraunLTNdumeleCE, et al.Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: A special report from the American Heart Association and American College of Cardiology. J Am Coll Cardiol2019; 73: 3153–3167.
3.
DawberTRMeadorsGFMooreFEJr. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health Nations Health1951; 41: 279–281.
4.
KannelWBDawberTRKaganA, et al.Factors of risk in the development of coronary heart disease–six year follow-up experience. The Framingham Study. Ann Inter Med1961; 55: 33–50.
5.
Beswick AD, Brindle P, Fahey T, et al. A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London: Royal College of General Practitioners, 2008.
6.
ConroyRMPyöräläKFitzgeraldAP, et al.Estimation of 10-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J2003; 24: 987–1003.
GoffDCLloyd-JonesDMBennettG, et al.2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014; 129: S49–S73.
9.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019; 74: 1429–1430.
10.
PiepoliMFHoesAWAgewallS, et al.2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
11.
RosselloXDorresteijnJAJanssenA, et al.Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol2019; 26: 1534–1544.
12.
Duprez DA, Duval S, Hoke L, et al. Early cardiovascular structural and functional abnormalities as a guide to future morbid events. Eur J Prev Cardiol 2020. Epub ahead of print, DOI: 10.1177/2047487320901416.
13.
YeboahJYoungRMcClellandRL, et al.Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol2016; 67: 139–147.
